Intelligent Bio Solutions Inc

Intelligent Bio Solutions Inc

INBS - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$5.84M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Intelligent Bio Solutions IncIntelligent Bio Solutions Inc-0.3--160%1.80.2
$-15.56

Current Fair Value

984.2% downside

Overvalued by 984.2% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$5.84 Million
Enterprise Value$1.70 Million
Earnings per Share$-8.44
Beta4.3
Outstanding Shares3,095,306

Return

Return on Equity-159.66%ROE
Return on Assets-88.88%
Return on Invested Capital-137.09%

Valuation & Multiples

P/E Ratio-0.26P/E Ratio
PEG2.37PEG
Price to Sales1.76Price to Sales
Price to Book Ratio0.88Price to Book Ratio
Enterprise Value to Revenue0.38
Enterprise Value to EBIT-0.14
Enterprise Value to Net Income-1
Total Debt to Enterprise1.05
Debt to Equity0.24Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
November 11, 2026
EPS Estimate
-$1.31
Consensus analyst estimate
Revenue Estimate
$1.40 M
Consensus analyst estimate

Next Earnings Call

Expected Date
February 11, 2027
EPS Estimate
-$1.36
Consensus analyst estimate
Revenue Estimate
$1.40 M
Consensus analyst estimate

Institutional Put/Call Ratio

Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.

Put/Call Ratio0.00000%
Total Calls-
Total Puts-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %25.66%▲ 13.40%
Total Invested$1.38M▲ 13.43%
Investors Holding12▲ 3.00%

About Intelligent Bio Solutions Inc

8 employees

GBS Inc. is on a mission to put the power of non-invasive, real-time diagnostic testing in the hands of patients and their primary health practitioners at point of care. With the world-first Biosensor Platform, GBS Inc. is developing and...

Intelligent Bio Solutions Insider Information FAQ

In the latest 13F quarter on Stockcircle, 1 top investor reduced or sold among tracked top investors. Changes are based on reported share counts in their quarterly filings, not day-to-day trading.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.